Pharmaceutical Portfolio Management: Global Disease Burden and Corporate Performance Metrics-Reference-Cited by-同舟云学术

Pharmaceutical Portfolio Management: Global Disease Burden and Corporate Performance Metrics

Published:2014-09 Issue:6 Volume:17 Page:732-738
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Daems Rutger,Maes Edith,Mehra Maneesha,Carroll Benjamin,Thomas Adrian

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference15 articles.

1. Market size in innovation: theory and evidence from the pharmaceutical industry;Acemoglu;Q J Econ,2004

2. Access to Medicine Index. Available from: http://www.accesstomedicineindex.org/. [Accessed September 15, 2013].

3. Productive Innovation Index. Available from: http://www.ideapharma.com/downloads/IDEAPharma_Production_innovation_index_2013.pdf. [Accessed September 15, 2013].

4. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study;Murray;Lancet,1997

5. Disability-adjusted life years for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010;Murray;Lancet,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pipeline progress and portfolio management of the top 30 pharma companies over the past two decades;Journal of Pharmaceutical Policy and Practice;2023-09-28

2. The social return on investment model: a systematic literature review;Meditari Accountancy Research;2022-03-10

3. Profiles of Malaria Research in Portugal;Science & Technology Studies;2019-09-16

4. Global Pharmaceutical Industry;Global Supply Chains in the Pharmaceutical Industry;2019

5. Análise de medicamentos novos registrados no Brasil na perspectiva do Sistema Único de Saúde e da carga de doença;Ciência & Saúde Coletiva;2018-01